THERAPEUTIC SUGGESTIONS IN OCCULT CHRONIC HYPERTRANSAMINASEMIA

March 1, 2012

Nurciu Adriana 1, Olariu Cristina 2, Olariu M. 2, Olteanu D. 1
1 Internal Medicine Clinic, Emergency Universitary Hospital Bucharest
2 National Institute of Infectious Diseases “ Prof. Dr. Matei Bals” Bucharest

Abstract

Less than 25% of asymptomatic adults have elevated levels of transaminases on a first evaluation, one third of these patients have normal values on a retest. From those who have elevated ALT on retest, some prove to suffer from an acute liver disease (with normal ALT in less than 6 months), and the others represent the category of chronic (more than 6 months) elevation of transaminases. The etiology of chronic hypertransaminasemia can be elucidated in 90% of the cases, due to liver disease with occult/ atypical evolution, or extra-hepatic causes of chronic elevation of transaminases. The 10% left represent the category of unexplained (obscure cause) elevation of transaminases. The occult/atypical evolution liver diseases are represented by chronic viral hepatitis (HBV, HCV), alcohol consumption, non-alcoholic steatohepatitis (NASH), congestion liver, drugs and liver toxic substances, autoimmune hepatitis, Wilson’s disease, α1 antitrypsin deficiency, parasitic diseases. The extra-hepatic causes that can determinate chronic elevations of transaminases are haemolysis, soft muscle diseases (polymyositis), occult celiac sprue, suprarenal insufficiency, thyroid pathology. There still remains 10% of the patients in witch the etiology can not be explained. Usually these patients are kept under surveillance, periodic reevaluation, and undergo a second liver biopsy; witch may reveal nonspecific lesions, NASH, chronic hepatitis, cirrhosis. There are cases in witch on the surveillance period it was observed a spontaneous normalization of transaminases. Chronic hypertransaminasemia is quite frequent, and has a high addressability to the physician from patients with this type of pathology, being for most of them a discovery by chance on a routine blood check. It is also important to have a clear diagnosis to start the specific treatment for those patients who can benefit out of it as soon as possible.

Previous article in this issue

LATE PRESENTER HIV POSITIVE PATIENT WITH SYSTEMIC CRYPTOCOCCAL INFECTION – CASE REVIEW

Next article in this issue

SURGICAL TREATMENT OF ESO-GASTRIC CANCER: ABDOMINAL APPROACH VS. ABDOMINO-THORACIC APPROACH